BLASTP 2.2.26 [Sep-21-2011]


Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer, 
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997), 
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs",  Nucleic Acids Res. 25:3389-3402.


Reference for compositional score matrix adjustment: Altschul, Stephen F., 
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.

Query= psy15111
         (93 letters)

Database: pdbaa 
           62,578 sequences; 14,973,337 total letters

Searching..................................................done



>pdb|2FWY|A Chain A, Structure Of Human Hsp90-Alpha Bound To The Potent Water
          Soluble Inhibitor Pu-H64
 pdb|2FWZ|A Chain A, Structure Of Human Hsp90-alpha Bound To The Potent Water
          Soluble Inhibitor Pu-h71
 pdb|2H55|A Chain A, Structure Of Human Hsp90-Alpha Bound To The Potent Water
          Soluble Inhibitor Pu-Dz8
 pdb|3O0I|A Chain A, Structure Of The Human Hsp90-Alpha N-Domain Bound To The
          Hsp90 Inhibitor Pu-H54
          Length = 256

 Score = 80.1 bits (196), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 43/63 (68%), Positives = 46/63 (73%), Gaps = 2/63 (3%)

Query: 14 GLIERVT--KNTTLMADNQSSGDGVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNS 71
          GL+ R +     T   D     + VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNS
Sbjct: 13 GLVPRGSHMPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNS 72

Query: 72 SDV 74
          SD 
Sbjct: 73 SDA 75


>pdb|3FT5|A Chain A, Structure Of Hsp90 Bound With A Novel Fragment
 pdb|3FT8|A Chain A, Structure Of Hsp90 Bound With A Noval Fragment.
 pdb|3HYY|A Chain A, Crystal Structure Of Hsp90 With Fragment 37-D04
 pdb|3HYZ|A Chain A, Crystal Structure Of Hsp90 With Fragment 42-C03
 pdb|3HYZ|B Chain B, Crystal Structure Of Hsp90 With Fragment 42-C03
 pdb|3HZ1|A Chain A, Crystal Structure Of Hsp90 With Fragments 37-D04 And
          42-C03
 pdb|3HZ5|A Chain A, Crystal Structure Of Hsp90 With Fragment Z064
 pdb|2XAB|A Chain A, Structure Of Hsp90 With An Inhibitor Bound
 pdb|2XAB|B Chain B, Structure Of Hsp90 With An Inhibitor Bound
 pdb|2XJX|A Chain A, Structre Of Hsp90 With Small Molecule Inhibitor Bound
 pdb|2XDK|A Chain A, Structure Of Hsp90 With Small Molecule Inhibitor Bound
 pdb|2XDL|A Chain A, Structure Of Hsp90 With Small Molecule Inhibitor Bound
 pdb|2XDS|A Chain A, Structre Of Hsp90 With Small Molecule Inhibitor Bound
 pdb|2XDX|A Chain A, Structre Of Hsp90 With Small Molecule Inhibitor Bound
 pdb|2XHR|A Chain A, Structure Of Hsp90 With Small Molecule Inhibitor Bound
 pdb|2XHT|A Chain A, Structure Of Hsp90 With Small Molecule Inhibitor Bound
 pdb|2XK2|A Chain A, Structre Of Hsp90 With Small Molecule Inhibitor Bound
          Length = 249

 Score = 80.1 bits (196), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 42/60 (70%), Positives = 46/60 (76%), Gaps = 5/60 (8%)

Query: 14 GLIERVTKNTTLMADNQSSGDGVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          GL+ R +     M + +     VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD
Sbjct: 13 GLVPRGSHMDQPMEEEE-----VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 67


>pdb|2XJG|A Chain A, Structure Of Hsp90 With Small Molecule Inhibitor Bound
 pdb|2XHX|A Chain A, Structure Of Hsp90 With Small Molecule Inhibitor Bound
          Length = 249

 Score = 79.7 bits (195), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 42/60 (70%), Positives = 46/60 (76%), Gaps = 5/60 (8%)

Query: 14 GLIERVTKNTTLMADNQSSGDGVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          GL+ R +     M + +     VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD
Sbjct: 13 GLVPRGSHMDQPMEEEE-----VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 67


>pdb|2XJJ|A Chain A, Structre Of Hsp90 With Small Molecule Inhibitor Bound
 pdb|2XJJ|B Chain B, Structre Of Hsp90 With Small Molecule Inhibitor Bound
          Length = 249

 Score = 79.7 bits (195), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 42/60 (70%), Positives = 46/60 (76%), Gaps = 5/60 (8%)

Query: 14 GLIERVTKNTTLMADNQSSGDGVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          GL+ R +     M + +     VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD
Sbjct: 13 GLVPRGSHMDQPMEEEE-----VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 67


>pdb|2XDU|A Chain A, Structre Of Hsp90 With Small Molecule Inhibitor Bound
          Length = 236

 Score = 79.3 bits (194), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 39/45 (86%), Positives = 41/45 (91%)

Query: 29 NQSSGDGVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          +Q   + VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD
Sbjct: 22 DQPMEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 66


>pdb|1UYI|A Chain A, Human Hsp90-Alpha With
          8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-
          Pent-9h-Purin-6-Ylamine
          Length = 236

 Score = 79.3 bits (194), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 39/47 (82%), Positives = 40/47 (85%)

Query: 28 DNQSSGDGVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDV 74
          D     + VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 
Sbjct: 9  DQPMEEEHVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDA 55


>pdb|2JJC|A Chain A, Hsp90 Alpha Atpase Domain With Bound Small Molecule
          Fragment
          Length = 218

 Score = 79.0 bits (193), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 39/45 (86%), Positives = 41/45 (91%)

Query: 29 NQSSGDGVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          +Q   + VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD
Sbjct: 5  DQPMEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 49


>pdb|2YEE|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
          Screening
          Length = 252

 Score = 79.0 bits (193), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 39/47 (82%), Positives = 40/47 (85%)

Query: 28 DNQSSGDGVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDV 74
          D     + VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 
Sbjct: 25 DQPMEEEHVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDA 71


>pdb|2YE7|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
          Screening
 pdb|2YE8|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
          Screening
 pdb|2YEI|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
          Screening
 pdb|2YEJ|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
          Screening
          Length = 252

 Score = 79.0 bits (193), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 39/46 (84%), Positives = 40/46 (86%)

Query: 28 DNQSSGDGVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          D     + VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD
Sbjct: 25 DQPMEEEHVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 70


>pdb|1YC1|A Chain A, Crystal Structures Of Human Hsp90alpha Complexed With
          Dihydroxyphenylpyrazoles
 pdb|1YC3|A Chain A, Crystal Structure Of Human Hsp90alpha Complexed With
          Dihydroxyphenylpyrazoles
 pdb|1YC4|A Chain A, Crystal Structure Of Human Hsp90alpha Complexed With
          Dihydroxyphenylpyrazoles
          Length = 264

 Score = 79.0 bits (193), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 38/39 (97%), Positives = 38/39 (97%)

Query: 36 VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDV 74
          VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 
Sbjct: 45 VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDA 83


>pdb|3QDD|A Chain A, Hsp90a N-Terminal Domain In Complex With Biib021
          Length = 237

 Score = 79.0 bits (193), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 38/39 (97%), Positives = 38/39 (97%)

Query: 36 VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDV 74
          VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 
Sbjct: 18 VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDA 56


>pdb|1UY6|A Chain A, Human Hsp90-Alpha With
          9-Butyl-8-(3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine
 pdb|1UY7|A Chain A, Human Hsp90-alpha With
          9-butyl-8-(4-methoxy-benzyl)-9h-purin-6-ylamine
 pdb|1UY8|A Chain A, Human Hsp90-Alpha With
          9-Butyl-8-(3-Trimethoxy-Benzyl)-9h-Purin-6ylamine
 pdb|1UY9|A Chain A, Human Hsp90-Alpha With
          8-Benzo[1,3]dioxol-,
          5-Ylmethyl-9-Butyl-9h-Purin-6-Ylamine
 pdb|1UYC|A Chain A, Human Hsp90-Alpha With
          9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine
 pdb|1UYD|A Chain A, Human Hsp90-Alpha With 9-Butyl-8-
          (2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine
 pdb|1UYE|A Chain A, Human Hsp90-Alpha With
          8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)
          -9-Pent-4-Ylnyl-9h-Purin-6-Ylamine
 pdb|1UYF|A Chain A, Human Hsp90-Alpha With
          8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)
          -2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine
 pdb|1UYG|A Chain A, Human Hsp90-Alpha With
          8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine
 pdb|1UYH|A Chain A, Human Hsp90-Alpha With 9-Butyl-8-
          (2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine
 pdb|1UYK|A Chain A, Human Hsp90-Alpha With
          8-Benzo[1,3]dioxol-,5-Ylmethyl-9-But
          Yl-2-Fluoro-9h-Purin-6-Ylamine
 pdb|1UYL|A Chain A, Structure-Activity Relationships In Purine-Based
          Inhibitor Binding To Hsp90 Isoforms
 pdb|2UWD|A Chain A, Inhibition Of The Hsp90 Molecular Chaperone In Vitro And
          In Vivo By Novel, Synthetic, Potent Resorcinylic
          Pyrazole, Isoxazole Amide Analogs
 pdb|2VCI|A Chain A, 4,5 Diaryl Isoxazole Hsp90 Chaperone Inhibitors:
          Potential Therapeutic Agents For The Treatment Of
          Cancer
 pdb|2VCJ|A Chain A, 4,5 Diaryl Isoxazole Hsp90 Chaperone Inhibitors:
          Potential Therapeutic Agents For The Treatment Of
          Cancer
 pdb|2WI1|A Chain A, Orally Active 2-Amino Thienopyrimidine Inhibitors Of The
          Hsp90 Chaperone
 pdb|2WI2|A Chain A, Orally Active 2-Amino Thienopyrimidine Inhibitors Of The
          Hsp90 Chaperone
 pdb|2WI2|B Chain B, Orally Active 2-Amino Thienopyrimidine Inhibitors Of The
          Hsp90 Chaperone
 pdb|2WI3|A Chain A, Orally Active 2-Amino Thienopyrimidine Inhibitors Of The
          Hsp90 Chaperone
 pdb|2WI4|A Chain A, Orally Active 2-Amino Thienopyrimidine Inhibitors Of The
          Hsp90 Chaperone
 pdb|2WI5|A Chain A, Orally Active 2-Amino Thienopyrimidine Inhibitors Of The
          Hsp90 Chaperone
 pdb|2WI6|A Chain A, Orally Active 2-Amino Thienopyrimidine Inhibitors Of The
          Hsp90 Chaperone
 pdb|2WI7|A Chain A, Orally Active 2-Amino Thienopyrimidine Inhibitors Of The
          Hsp90 Chaperone
 pdb|4FCP|A Chain A, Targetting Conserved Water Molecules: Design Of
          4-Aryl-5-Cyanopyrrolo [2,3-D] Pyrimidine Hsp90
          Inhibitors Using Fragment-Based Screening And
          Structure-Based Optimization
 pdb|4FCP|B Chain B, Targetting Conserved Water Molecules: Design Of
          4-Aryl-5-Cyanopyrrolo [2,3-D] Pyrimidine Hsp90
          Inhibitors Using Fragment-Based Screening And
          Structure-Based Optimization
 pdb|4FCQ|A Chain A, Targeting Conserved Water Molecules: Design Of 4-Aryl-5-
          Cyanopyrrolo[2,3-D]pyrimidine Hsp90 Inhibitors Using
          Fragment-Based Screening And Structure-Based
          Optimization
 pdb|4FCR|A Chain A, Targeting Conserved Water Molecules: Design Of 4-Aryl-5-
          Cyanopyrrolo[2,3-D]pyrimidine Hsp90 Inhibitors Using
          Fragment-Based Screening And Structure-Based
          Optimization
          Length = 236

 Score = 79.0 bits (193), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 38/39 (97%), Positives = 38/39 (97%)

Query: 36 VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDV 74
          VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 
Sbjct: 17 VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDA 55


>pdb|2CCS|A Chain A, Human Hsp90 With
          4-Chloro-6-(4-Piperazin-1-Yl-1h-Pyrazol-3-
          Yl)-Benzene-1,2-Diol
 pdb|2CCT|A Chain A, Human Hsp90 With 5-(5-Chloro-2,4-Dihydroxy-Phenyl)-4-
          Piperazin-1-Yl-2h-Pyrazole-3-Carboxylic Acid Ethylamide
 pdb|2CCU|A Chain A, Human Hsp90 With 4-Chloro-6-(4-(4-(4-Methanesulphonyl-
          Benzyl)-Pierazin-1-Yl)-1h-Pyrazol-3-Yl)-Benzene-1,
          3-Diol
          Length = 236

 Score = 79.0 bits (193), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 38/38 (100%), Positives = 38/38 (100%)

Query: 36 VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD
Sbjct: 17 VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 54


>pdb|3BM9|A Chain A, Discovery Of Benzisoxazoles As Potent Inhibitors Of
          Chaperone Hsp90
 pdb|3BMY|A Chain A, Discovery Of Benzisoxazoles As Potent Inhibitors Of
          Chaperone Hsp90
 pdb|3QTF|A Chain A, Design And Sar Of Macrocyclic Hsp90 Inhibitors With
          Increased Metabolic Stability And Potent
          Cell-Proliferation Activity
 pdb|3R91|A Chain A, Macrocyclic Lactams As Potent Hsp90 Inhibitors With
          Excellent Tumor Exposure And Extended Biomarker
          Activity.
 pdb|3R92|A Chain A, Discovery Of A Macrocyclic O-Aminobenzamide Hsp90
          Inhibitor With Heterocyclic Tether That Shows Extended
          Biomarker Activity And In Vivo Efficacy In A Mouse
          Xenograft Model.
 pdb|3RKZ|A Chain A, Discovery Of A Stable Macrocyclic O-Aminobenzamide Hsp90
          Inhibitor Capable Of Significantly Decreasing Tumor
          Volume In A Mouse Xenograft Model
          Length = 226

 Score = 79.0 bits (193), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 39/44 (88%), Positives = 40/44 (90%)

Query: 30 QSSGDGVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          Q   + VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD
Sbjct: 1  QPMEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 44


>pdb|2YE2|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
          Screening
 pdb|2YE3|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
          Screening
 pdb|2YE4|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
          Screening
 pdb|2YE5|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
          Screening
 pdb|2YE6|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
          Screening
 pdb|2YE9|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
          Screening
 pdb|2YEA|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
          Screening
 pdb|2YEB|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
          Screening
 pdb|2YEC|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
          Screening
 pdb|2YED|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
          Screening
 pdb|2YEF|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
          Screening
 pdb|2YEG|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
          Screening
 pdb|2YEG|B Chain B, Hsp90 Inhibitors And Drugs From Fragment And Virtual
          Screening
 pdb|2YEH|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
          Screening
          Length = 252

 Score = 79.0 bits (193), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 38/38 (100%), Positives = 38/38 (100%)

Query: 36 VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD
Sbjct: 33 VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 70


>pdb|4AWO|A Chain A, Complex Of Hsp90 Atpase Domain With Tropane Derived
          Inhibitors
 pdb|4AWO|B Chain B, Complex Of Hsp90 Atpase Domain With Tropane Derived
          Inhibitors
 pdb|4AWP|A Chain A, Complex Of Hsp90 Atpase Domain With Tropane Derived
          Inhibitors
 pdb|4AWP|B Chain B, Complex Of Hsp90 Atpase Domain With Tropane Derived
          Inhibitors
 pdb|4AWQ|A Chain A, Complex Of Hsp90 Atpase Domain With Tropane Derived
          Inhibitors
 pdb|4AWQ|B Chain B, Complex Of Hsp90 Atpase Domain With Tropane Derived
          Inhibitors
          Length = 230

 Score = 78.6 bits (192), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 39/47 (82%), Positives = 41/47 (87%)

Query: 27 ADNQSSGDGVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          +D     + VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD
Sbjct: 2  SDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 48


>pdb|2BSM|A Chain A, Novel, Potent Small Molecule Inhibitors Of The Molecular
          Chaperone Hsp90 Discovered Through Structure-Based
          Design
 pdb|2BT0|A Chain A, Novel, Potent Small Molecule Inhibitors Of The Molecular
          Chaperone Hsp90 Discovered Through Structure-Based
          Design
 pdb|2BT0|B Chain B, Novel, Potent Small Molecule Inhibitors Of The Molecular
          Chaperone Hsp90 Discovered Through Structure-Based
          Design
 pdb|2BYH|A Chain A, 3-(5-Chloro-2,4-Dihydroxyphenyl)-Pyrazole-4-Carboxamides
          As Inhibitors Of The Hsp90 Molecular Chaperone
 pdb|2BYI|A Chain A, 3-(5-Chloro-2,4-Dihydroxyphenyl)-Pyrazole-4-Carboxamides
          As Inhibitors Of The Hsp90 Molecular Chaperone
 pdb|2BZ5|A Chain A, Structure-Based Discovery Of A New Class Of Hsp90
          Inhibitors
 pdb|2BZ5|B Chain B, Structure-Based Discovery Of A New Class Of Hsp90
          Inhibitors
          Length = 235

 Score = 78.6 bits (192), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 38/39 (97%), Positives = 38/39 (97%)

Query: 36 VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDV 74
          VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 
Sbjct: 16 VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDA 54


>pdb|2YI0|A Chain A, Structural Characterization Of
          5-Aryl-4-(5-Substituted-2-4-
          Dihydroxyphenyl)-1,2,3-Thiadiazole Hsp90 Inhibitors.
 pdb|2YI5|A Chain A, Structural Characterization Of
          5-Aryl-4-(5-Substituted-2-4-
          Dihydroxyphenyl)-1,2,3-Thiadiazole Hsp90 Inhibitors.
 pdb|2YI6|A Chain A, Structural Characterization Of
          5-Aryl-4-(5-Substituted-2-
          4-Dihydroxyphenyl)-1,2,3-Thiadiazole Hsp90 Inhibitors.
 pdb|2YI7|A Chain A, Structural Characterization Of
          5-Aryl-4-(5-Substituted-2-4-
          Dihydroxyphenyl)-1,2,3-Thiadiazole Hsp90 Inhibitors
          Length = 229

 Score = 78.6 bits (192), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 39/46 (84%), Positives = 40/46 (86%)

Query: 28 DNQSSGDGVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          D     + VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD
Sbjct: 9  DQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 54


>pdb|1BYQ|A Chain A, Hsp90 N-Terminal Domain Bound To Adp-Mg
 pdb|1YER|A Chain A, Human Hsp90 Geldanamycin-Binding Domain, "closed"
          Conformation
 pdb|1YES|A Chain A, Human Hsp90 Geldanamycin-Binding Domain, "open"
          Conformation
 pdb|1YET|A Chain A, Geldanamycin Bound To The Hsp90 Geldanamycin-Binding
          Domain
          Length = 228

 Score = 78.6 bits (192), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 38/38 (100%), Positives = 38/38 (100%)

Query: 36 VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD
Sbjct: 9  VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 46


>pdb|3D0B|A Chain A, Crystal Structure Of Benzamide
          Tetrahydro-4h-Carbazol-4-One Bound To Hsp90
 pdb|3MNR|P Chain P, Crystal Structure Of Benzamide Snx-1321 Bound To Hsp90
          Length = 232

 Score = 78.6 bits (192), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 38/38 (100%), Positives = 38/38 (100%)

Query: 36 VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD
Sbjct: 17 VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 54


>pdb|4EGH|A Chain A, Hsp90-Alpha Atpase Domain In Complex With
          (4-Hydroxyphenyl)morpholin- 4-Yl Methanone
 pdb|4EGI|A Chain A, Hsp90-Alpha Atpase Domain In Complex With
          2-Amino-4-Ethylthio-6- Methyl-1,3,5-Triazine
 pdb|4EGK|A Chain A, Human Hsp90-Alpha Atpase Domain Bound To Radicicol
          Length = 232

 Score = 78.6 bits (192), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 38/38 (100%), Positives = 38/38 (100%)

Query: 36 VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD
Sbjct: 13 VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 50


>pdb|4EEH|A Chain A, Hsp90 Alpha N-Terminal Domain In Complex With An
          Inhibitor 3-(4- Hydroxy-Phenyl)-1h-Indazol-6-Ol
 pdb|4EFT|A Chain A, Hsp90 Alpha N-Terminal Domain In Complex With An
          Inhibitor 3-
          Cyclohexyl-2-(6-Hydroxy-1h-Indazol-3-Yl)-Propionitrile
 pdb|4EFU|A Chain A, Hsp90 Alpha N-Terminal Domain In Complex With An
          Inhibitor 6-Hydroxy-
          3-(3-Methyl-Benzyl)-1h-Indazole-5-Carboxylic Acid
          Benzyl-Methyl-Amide
          Length = 229

 Score = 78.6 bits (192), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 38/38 (100%), Positives = 38/38 (100%)

Query: 36 VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD
Sbjct: 10 VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 47


>pdb|3B24|A Chain A, Hsp90 Alpha N-Terminal Domain In Complex With An
          Aminotriazine Fragment Molecule
 pdb|3B24|B Chain B, Hsp90 Alpha N-Terminal Domain In Complex With An
          Aminotriazine Fragment Molecule
 pdb|3B25|A Chain A, Hsp90 Alpha N-Terminal Domain In Complex With An
          Inhibitor Ch4675194
 pdb|3B26|A Chain A, Hsp90 Alpha N-Terminal Domain In Complex With An
          Inhibitor Ro1127850
 pdb|3B26|B Chain B, Hsp90 Alpha N-Terminal Domain In Complex With An
          Inhibitor Ro1127850
 pdb|3B27|A Chain A, Hsp90 Alpha N-Terminal Domain In Complex With An
          Inhibitor Ro4919127
 pdb|3B28|A Chain A, Hsp90 Alpha N-Terminal Domain In Complex With An
          Inhibitor Ch5015765
 pdb|3B28|B Chain B, Hsp90 Alpha N-Terminal Domain In Complex With An
          Inhibitor Ch5015765
 pdb|3VHA|A Chain A, Hsp90 Alpha N-Terminal Domain In Complex With A
          Macrocyclic Inhibitor
 pdb|3VHC|A Chain A, Hsp90 Alpha N-Terminal Domain In Complex With A
          Macrocyclic Inhibitor
 pdb|3VHD|A Chain A, Hsp90 Alpha N-Terminal Domain In Complex With A
          Macrocyclic Inhibitor, Ch5164840
 pdb|3VHD|B Chain B, Hsp90 Alpha N-Terminal Domain In Complex With A
          Macrocyclic Inhibitor, Ch5164840
          Length = 229

 Score = 78.6 bits (192), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 38/38 (100%), Positives = 38/38 (100%)

Query: 36 VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD
Sbjct: 10 VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 47


>pdb|3R4M|A Chain A, Optimization Of Potent, Selective, And Orally
          Bioavailable Pyrrolodinopyrimidine-Containing
          Inhibitors Of Heat Shock Protein 90. Identification Of
          Development Candidate 2-Amino-4-{4-Chloro-2-[2-(4-
          Fluoro-1h-Pyrazol-1-Yl)ethoxy]-6-Methylphenyl}-N-(2,2-
          Difluoropropyl)-5,7-Dihydro-6h-Pyrrolo[3,
          4-D]pyrimidine-6-Carboxamide
 pdb|3T0H|A Chain A, Structure Insights Into Mechanisms Of Atp Hydrolysis And
          The Activation Of Human Hsp90
 pdb|3T0Z|A Chain A, Hsp90 N-Terminal Domain Bound To Atp
 pdb|3T10|A Chain A, Hsp90 N-Terminal Domain Bound To Acp
 pdb|3T1K|A Chain A, Hsp90 N-Terminal Domain Bound To Anp
 pdb|3T1K|B Chain B, Hsp90 N-Terminal Domain Bound To Anp
 pdb|3T2S|A Chain A, Hsp90 N-Terminal Domain Bound To Ags
 pdb|3T2S|B Chain B, Hsp90 N-Terminal Domain Bound To Ags
          Length = 228

 Score = 78.6 bits (192), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 38/38 (100%), Positives = 38/38 (100%)

Query: 36 VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD
Sbjct: 9  VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 46


>pdb|3INW|A Chain A, Hsp90 N-Terminal Domain With Pochoxime A
 pdb|3INX|A Chain A, Hsp90 N-Terminal Domain With Pochoxime B
          Length = 228

 Score = 78.6 bits (192), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 38/38 (100%), Positives = 38/38 (100%)

Query: 36 VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD
Sbjct: 9  VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 46


>pdb|3HHU|A Chain A, Human Heat-Shock Protein 90 (Hsp90) In Complex With
          {4-[3- (2,4-Dihydroxy-5-Isopropyl-Phenyl)-5-Thioxo-
          1,5-Dihydro- [1,2,4]triazol-4-Yl]-Benzyl}-Carbamic Acid
          Ethyl Ester {zk 2819}
 pdb|3HHU|B Chain B, Human Heat-Shock Protein 90 (Hsp90) In Complex With
          {4-[3- (2,4-Dihydroxy-5-Isopropyl-Phenyl)-5-Thioxo-
          1,5-Dihydro- [1,2,4]triazol-4-Yl]-Benzyl}-Carbamic Acid
          Ethyl Ester {zk 2819}
          Length = 224

 Score = 78.6 bits (192), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 39/46 (84%), Positives = 40/46 (86%)

Query: 28 DNQSSGDGVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          D     + VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD
Sbjct: 9  DQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 54


>pdb|3TUH|A Chain A, Crystal Structure Of The N-Terminal Domain Of An Hsp90
          In The Presence Of An The Inhibitor Ganetespib
 pdb|3TUH|B Chain B, Crystal Structure Of The N-Terminal Domain Of An Hsp90
          In The Presence Of An The Inhibitor Ganetespib
          Length = 209

 Score = 78.6 bits (192), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 38/38 (100%), Positives = 38/38 (100%)

Query: 36 VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD
Sbjct: 2  VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 39


>pdb|3K98|A Chain A, Hsp90 N-Terminal Domain In Complex With
          (1r)-2-(5-Chloro-2,
          4-Dihydroxybenzoyl)-N-Ethylisoindoline-1-Carboxamide
 pdb|3K98|B Chain B, Hsp90 N-Terminal Domain In Complex With
          (1r)-2-(5-Chloro-2,
          4-Dihydroxybenzoyl)-N-Ethylisoindoline-1-Carboxamide
 pdb|3K99|A Chain A, Hsp90 N-Terminal Domain In Complex With
          4-(1,3-Dihydro-2h-
          Isoindol-2-Ylcarbonyl)benzene-1,3-Diol
 pdb|3K99|B Chain B, Hsp90 N-Terminal Domain In Complex With
          4-(1,3-Dihydro-2h-
          Isoindol-2-Ylcarbonyl)benzene-1,3-Diol
 pdb|3K99|C Chain C, Hsp90 N-Terminal Domain In Complex With
          4-(1,3-Dihydro-2h-
          Isoindol-2-Ylcarbonyl)benzene-1,3-Diol
 pdb|3K99|D Chain D, Hsp90 N-Terminal Domain In Complex With
          4-(1,3-Dihydro-2h-
          Isoindol-2-Ylcarbonyl)benzene-1,3-Diol
          Length = 232

 Score = 78.6 bits (192), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 39/46 (84%), Positives = 40/46 (86%)

Query: 28 DNQSSGDGVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          D     + VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD
Sbjct: 2  DQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 47


>pdb|3K97|A Chain A, Hsp90 N-Terminal Domain In Complex With
          4-Chloro-6-{[(2r)-2-
          (2-Methylphenyl)pyrrolidin-1-Yl]carbonyl}benzene-1,
          3-Diol
          Length = 251

 Score = 78.6 bits (192), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 38/38 (100%), Positives = 38/38 (100%)

Query: 36 VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD
Sbjct: 32 VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 69


>pdb|3EKO|A Chain A, Dihydroxylphenyl Amides As Inhibitors Of The Hsp90
          Molecular Chaperone
 pdb|3EKO|B Chain B, Dihydroxylphenyl Amides As Inhibitors Of The Hsp90
          Molecular Chaperone
 pdb|3EKR|A Chain A, Dihydroxylphenyl Amides As Inhibitors Of The Hsp90
          Molecular Chaperone
 pdb|3EKR|B Chain B, Dihydroxylphenyl Amides As Inhibitors Of The Hsp90
          Molecular Chaperone
 pdb|3HEK|A Chain A, Hsp90 N-Terminal Domain In Complex With 1-{4-[(2r)-1-(5-
          Chloro-2,4-Dihydroxybenzoyl)pyrrolidin-2-Yl]benzyl}-3,
          3- Difluoropyrrolidinium
 pdb|3HEK|B Chain B, Hsp90 N-Terminal Domain In Complex With 1-{4-[(2r)-1-(5-
          Chloro-2,4-Dihydroxybenzoyl)pyrrolidin-2-Yl]benzyl}-3,
          3- Difluoropyrrolidinium
 pdb|3R4N|A Chain A, Optimization Of Potent, Selective, And Orally
          Bioavailable Pyrrolodinopyrimidine-Containing
          Inhibitors Of Heat Shock Protein 90. Identification Of
          Development Candidate 2-Amino-4-{4-Chloro-2-[2-(4-
          Fluoro-1h-Pyrazol-1-Yl)ethoxy]-6-Methylphenyl}-N-(2,2-
          Difluoropropyl)-5,7-Dihydro-6h-Pyrrolo[3,
          4-D]pyrimidine-6-Carboxamide
 pdb|3R4N|B Chain B, Optimization Of Potent, Selective, And Orally
          Bioavailable Pyrrolodinopyrimidine-Containing
          Inhibitors Of Heat Shock Protein 90. Identification Of
          Development Candidate 2-Amino-4-{4-Chloro-2-[2-(4-
          Fluoro-1h-Pyrazol-1-Yl)ethoxy]-6-Methylphenyl}-N-(2,2-
          Difluoropropyl)-5,7-Dihydro-6h-Pyrrolo[3,
          4-D]pyrimidine-6-Carboxamide
 pdb|3R4O|A Chain A, Optimization Of Potent, Selective, And Orally
          Bioavailable Pyrrolodinopyrimidine-Containing
          Inhibitors Of Heat Shock Protein 90. Identification Of
          Development Candidate 2-Amino-4-{4-Chloro-2-[2-(4-
          Fluoro-1h-Pyrazol-1-Yl)ethoxy]-6-Methylphenyl}-N-(2,2-
          Difluoropropyl)-5,7-Dihydro-6h-Pyrrolo[3,
          4-D]pyrimidine-6-Carboxamide
 pdb|3R4O|B Chain B, Optimization Of Potent, Selective, And Orally
          Bioavailable Pyrrolodinopyrimidine-Containing
          Inhibitors Of Heat Shock Protein 90. Identification Of
          Development Candidate 2-Amino-4-{4-Chloro-2-[2-(4-
          Fluoro-1h-Pyrazol-1-Yl)ethoxy]-6-Methylphenyl}-N-(2,2-
          Difluoropropyl)-5,7-Dihydro-6h-Pyrrolo[3,
          4-D]pyrimidine-6-Carboxamide
 pdb|3R4P|A Chain A, Optimization Of Potent, Selective, And Orally
          Bioavailable Pyrrolodinopyrimidine-Containing
          Inhibitors Of Heat Shock Protein 90. Identification Of
          Development Candidate 2-Amino-4-{4-Chloro-2-[2-(4-
          Fluoro-1h-Pyrazol-1-Yl)ethoxy]-6-Methylphenyl}-N-(2,2-
          Difluoropropyl)-5,7-Dihydro-6h-Pyrrolo[3,
          4-D]pyrimidine-6-Carboxamide
 pdb|3R4P|B Chain B, Optimization Of Potent, Selective, And Orally
          Bioavailable Pyrrolodinopyrimidine-Containing
          Inhibitors Of Heat Shock Protein 90. Identification Of
          Development Candidate 2-Amino-4-{4-Chloro-2-[2-(4-
          Fluoro-1h-Pyrazol-1-Yl)ethoxy]-6-Methylphenyl}-N-(2,2-
          Difluoropropyl)-5,7-Dihydro-6h-Pyrrolo[3,
          4-D]pyrimidine-6-Carboxamide
 pdb|3RLP|A Chain A, Co-Crystal Structure Of The Hsp90 Atp Binding Domain In
          Complex With
          4-(2,
          4-Dichloro-5-Methoxyphenyl)-6-Methylpyrimidin-2-Amine
 pdb|3RLP|B Chain B, Co-Crystal Structure Of The Hsp90 Atp Binding Domain In
          Complex With
          4-(2,
          4-Dichloro-5-Methoxyphenyl)-6-Methylpyrimidin-2-Amine
 pdb|3RLQ|A Chain A, Co-Crystal Structure Of The Hsp90 Atp Binding Domain In
          Complex With
          4-(2,4-Dichloro-5-Methoxyphenyl)-2-Methyl-7h-Pyrrolo[2,
          3- D]pyrimidine-5- Carbonitrile
 pdb|3RLQ|B Chain B, Co-Crystal Structure Of The Hsp90 Atp Binding Domain In
          Complex With
          4-(2,4-Dichloro-5-Methoxyphenyl)-2-Methyl-7h-Pyrrolo[2,
          3- D]pyrimidine-5- Carbonitrile
 pdb|3RLR|A Chain A, Co-Crystal Structure Of The Hsp90 Atp Binding Domain In
          Complex With
          4-(2,4-Dichloro-5-Methoxyphenyl)-2,
          6-Dimethyl-7h-Pyrrolo[2,3- D]pyrimidine-5-Carbonitrile
 pdb|3RLR|B Chain B, Co-Crystal Structure Of The Hsp90 Atp Binding Domain In
          Complex With
          4-(2,4-Dichloro-5-Methoxyphenyl)-2,
          6-Dimethyl-7h-Pyrrolo[2,3- D]pyrimidine-5-Carbonitrile
          Length = 226

 Score = 78.6 bits (192), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 39/46 (84%), Positives = 40/46 (86%)

Query: 28 DNQSSGDGVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          D     + VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD
Sbjct: 2  DQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 47


>pdb|2QFO|A Chain A, Hsp90 Complexed With A143571 And A516383
 pdb|2QFO|B Chain B, Hsp90 Complexed With A143571 And A516383
 pdb|2QG0|A Chain A, Hsp90 Complexed With A943037
 pdb|2QG0|B Chain B, Hsp90 Complexed With A943037
          Length = 207

 Score = 78.6 bits (192), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 38/38 (100%), Positives = 38/38 (100%)

Query: 36 VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD
Sbjct: 1  VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 38


>pdb|2QF6|A Chain A, Hsp90 Complexed With A56322
 pdb|2QF6|B Chain B, Hsp90 Complexed With A56322
 pdb|2QF6|C Chain C, Hsp90 Complexed With A56322
 pdb|2QF6|D Chain D, Hsp90 Complexed With A56322
 pdb|2QG2|A Chain A, Hsp90 Complexed With A917985
 pdb|3OW6|A Chain A, Crystal Structure Of Hsp90 With N-Aryl-Benzimidazolone I
 pdb|3OWB|A Chain A, Crystal Structure Of Hsp90 With Ver-49009
 pdb|3OWD|A Chain A, Crystal Structure Of Hsp90 With N-Aryl-Benzimidazolone
          Ii
          Length = 207

 Score = 78.6 bits (192), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 38/38 (100%), Positives = 38/38 (100%)

Query: 36 VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD
Sbjct: 1  VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 38


>pdb|2K5B|A Chain A, Human Cdc37-Hsp90 Docking Model Based On Nmr
          Length = 210

 Score = 78.6 bits (192), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 38/38 (100%), Positives = 38/38 (100%)

Query: 36 VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD
Sbjct: 4  VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 41


>pdb|1OSF|A Chain A, Human Hsp90 In Complex With 17-desmethoxy-17-n,n-
          Dimethylaminoethylamino-geldanamycin
          Length = 215

 Score = 78.6 bits (192), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 38/38 (100%), Positives = 38/38 (100%)

Query: 36 VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD
Sbjct: 9  VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 46


>pdb|2YJW|A Chain A, Tricyclic Series Of Hsp90 Inhibitors
 pdb|2YJX|A Chain A, Tricyclic Series Of Hsp90 Inhibitors
 pdb|2YK2|A Chain A, Tricyclic Series Of Hsp90 Inhibitors
 pdb|2YKB|A Chain A, Tricyclic Series Of Hsp90 Inhibitors
 pdb|2YKC|A Chain A, Tricyclic Series Of Hsp90 Inhibitors
 pdb|2YKE|A Chain A, Tricyclic Series Of Hsp90 Inhibitors
 pdb|2YKI|A Chain A, Tricyclic Series Of Hsp90 Inhibitors
 pdb|2YKJ|A Chain A, Tricyclic Series Of Hsp90 Inhibitors
 pdb|2YK9|A Chain A, Tricyclic Series Of Hsp90 Inhibitors
          Length = 209

 Score = 77.0 bits (188), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 37/38 (97%), Positives = 38/38 (100%)

Query: 36 VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          +ETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD
Sbjct: 3  METFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 40


>pdb|4GQT|A Chain A, N-Terminal Domain Of C. Elegans Hsp90
 pdb|4GQT|B Chain B, N-Terminal Domain Of C. Elegans Hsp90
          Length = 227

 Score = 74.3 bits (181), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 35/40 (87%), Positives = 38/40 (95%)

Query: 34 DGVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          +  ETFAFQAEIAQLMSLIINTFYSNKEI+LRELISN+SD
Sbjct: 6  ENAETFAFQAEIAQLMSLIINTFYSNKEIYLRELISNASD 45


>pdb|1UYM|A Chain A, Human Hsp90-Beta With Pu3
          (9-Butyl-8(3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine)
          Length = 220

 Score = 74.3 bits (181), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 35/36 (97%), Positives = 36/36 (100%)

Query: 38 TFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          TFAFQAEIAQLMSLIINTFYSNKEIFLRELISN+SD
Sbjct: 13 TFAFQAEIAQLMSLIINTFYSNKEIFLRELISNASD 48


>pdb|3NMQ|A Chain A, Hsp90b N-Terminal Domain In Complex With Ec44, A
          Pyrrolo-Pyrimidine Methoxypyridine Inhibitor
          Length = 239

 Score = 73.9 bits (180), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 35/36 (97%), Positives = 36/36 (100%)

Query: 38 TFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          TFAFQAEIAQLMSLIINTFYSNKEIFLRELISN+SD
Sbjct: 18 TFAFQAEIAQLMSLIINTFYSNKEIFLRELISNASD 53


>pdb|3O6O|A Chain A, Crystal Structure Of The N-Terminal Domain Of An Hsp90
          From Trypanosoma Brucei, Tb10.26.1080 In The Presence
          Of An The Inhibitor Biib021
 pdb|3O6O|B Chain B, Crystal Structure Of The N-Terminal Domain Of An Hsp90
          From Trypanosoma Brucei, Tb10.26.1080 In The Presence
          Of An The Inhibitor Biib021
          Length = 214

 Score = 73.9 bits (180), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 36/37 (97%), Positives = 36/37 (97%)

Query: 37 ETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          ETFAFQAEI QLMSLIINTFYSNKEIFLRELISNSSD
Sbjct: 4  ETFAFQAEINQLMSLIINTFYSNKEIFLRELISNSSD 40


>pdb|3OPD|A Chain A, Crystal Structure Of The N-Terminal Domain Of An Hsp90
          From Trypanosoma Brucei, Tb10.26.1080 In The Presence
          Of A Benzamide Derivative
 pdb|3OPD|B Chain B, Crystal Structure Of The N-Terminal Domain Of An Hsp90
          From Trypanosoma Brucei, Tb10.26.1080 In The Presence
          Of A Benzamide Derivative
 pdb|3OPD|C Chain C, Crystal Structure Of The N-Terminal Domain Of An Hsp90
          From Trypanosoma Brucei, Tb10.26.1080 In The Presence
          Of A Benzamide Derivative
 pdb|3OMU|A Chain A, Crystal Structure Of The N-Terminal Domain Of An Hsp90
          From Trypanosoma Brucei, Tb10.26.1080 In The Presence
          Of A Thienopyrimidine Derivative
 pdb|3OMU|B Chain B, Crystal Structure Of The N-Terminal Domain Of An Hsp90
          From Trypanosoma Brucei, Tb10.26.1080 In The Presence
          Of A Thienopyrimidine Derivative
          Length = 231

 Score = 73.6 bits (179), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 36/37 (97%), Positives = 36/37 (97%)

Query: 37 ETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          ETFAFQAEI QLMSLIINTFYSNKEIFLRELISNSSD
Sbjct: 21 ETFAFQAEINQLMSLIINTFYSNKEIFLRELISNSSD 57


>pdb|3H80|A Chain A, Crystal Structure Of The Amino-Terminal Domain Of Hsp90
          From Leishmania Major, Lmjf33.0312:m1-K213
 pdb|3Q5J|A Chain A, Crystal Structure Of The Amino-Terminal Domain Of Hsp90
          From Leishmania Major, Lmjf33.0312:m1-K213 In The
          Presence Of 17-Dmap- Geldanamycin
 pdb|3Q5K|A Chain A, Crystal Structure Of The Amino-Terminal Domain Of Hsp90
          From Leishmania Major, Lmjf33.0312:m1-K213 In The
          Presence Of An Inhibitor
 pdb|3Q5L|A Chain A, Crystal Structure Of The Amino-Terminal Domain Of Hsp90
          From Leishmania Major, Lmjf33.0312:m1-K 213 In The
          Presence Of 17-Aep- Geldanamycin
 pdb|3Q5L|B Chain B, Crystal Structure Of The Amino-Terminal Domain Of Hsp90
          From Leishmania Major, Lmjf33.0312:m1-K 213 In The
          Presence Of 17-Aep- Geldanamycin
 pdb|3Q5L|C Chain C, Crystal Structure Of The Amino-Terminal Domain Of Hsp90
          From Leishmania Major, Lmjf33.0312:m1-K 213 In The
          Presence Of 17-Aep- Geldanamycin
 pdb|3Q5L|D Chain D, Crystal Structure Of The Amino-Terminal Domain Of Hsp90
          From Leishmania Major, Lmjf33.0312:m1-K 213 In The
          Presence Of 17-Aep- Geldanamycin
 pdb|3U67|A Chain A, Crystal Structure Of The N-Terminal Domain Of Hsp90 From
          Leishmania Major(Lmjf33.0312)in Complex With Adp
          Length = 231

 Score = 72.8 bits (177), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 35/38 (92%), Positives = 36/38 (94%)

Query: 37 ETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDV 74
          ETFAFQAEI QLMSLIINTFYSNKEIFLRELISN+SD 
Sbjct: 21 ETFAFQAEINQLMSLIINTFYSNKEIFLRELISNASDA 58


>pdb|2XCM|A Chain A, Complex Of Hsp90 N-Terminal, Sgt1 Cs And Rar1 Chord2
          Domain
 pdb|2XCM|B Chain B, Complex Of Hsp90 N-Terminal, Sgt1 Cs And Rar1 Chord2
          Domain
          Length = 214

 Score = 72.8 bits (177), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 35/45 (77%), Positives = 39/45 (86%)

Query: 29 NQSSGDGVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          + ++    ETFAFQAEI QL+SLIINTFYSNKEIFLRELISNSSD
Sbjct: 1  HHAAATETETFAFQAEINQLLSLIINTFYSNKEIFLRELISNSSD 45


>pdb|2JKI|A Chain A, Complex Of Hsp90 N-terminal And Sgt1 Cs Domain
 pdb|2JKI|B Chain B, Complex Of Hsp90 N-terminal And Sgt1 Cs Domain
 pdb|2JKI|C Chain C, Complex Of Hsp90 N-terminal And Sgt1 Cs Domain
          Length = 223

 Score = 72.4 bits (176), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 35/37 (94%), Positives = 36/37 (97%)

Query: 37 ETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          ETFAFQAEI QL+SLIINTFYSNKEIFLRELISNSSD
Sbjct: 12 ETFAFQAEINQLLSLIINTFYSNKEIFLRELISNSSD 48


>pdb|1ZW9|A Chain A, Yeast Hsp82 In Complex With The Novel Hsp90 Inhibitor
          8-(6-Bromo-
          Benzo[1,
          3]dioxol-5-Ylsulfanyl)-9-(3-Isopropylamino-Propyl)-
          Adenine
 pdb|1ZWH|A Chain A, Yeast Hsp82 In Complex With The Novel Hsp90 Inhibitor
          Radester Amine
 pdb|2FXS|A Chain A, Yeast Hsp82 In Complex With The Novel Hsp90 Inhibitor
          Radamide
          Length = 240

 Score = 68.9 bits (167), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 33/37 (89%), Positives = 34/37 (91%)

Query: 37 ETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          ETF FQAEI QLMSLIINT YSNKEIFLRELISN+SD
Sbjct: 24 ETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASD 60


>pdb|3C0E|A Chain A, Yeast Hsp82 N-Terminal Domain: Effects Of Mutants 98-99
          Ks- Aa
 pdb|3C11|A Chain A, Yeast Hsp82 N-Terminal Domain-Geldanamycin Complex:
          Effects Of Mutants 98-99 Ks-Aa
          Length = 240

 Score = 68.9 bits (167), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 33/37 (89%), Positives = 34/37 (91%)

Query: 37 ETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          ETF FQAEI QLMSLIINT YSNKEIFLRELISN+SD
Sbjct: 24 ETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASD 60


>pdb|1BGQ|A Chain A, Radicicol Bound To The Atp Binding Site Of The
          N-Terminal Domain Of The Yeast Hsp90 Chaperone
          Length = 225

 Score = 68.9 bits (167), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 34/41 (82%), Positives = 35/41 (85%)

Query: 33 GDGVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          G   ETF FQAEI QLMSLIINT YSNKEIFLRELISN+SD
Sbjct: 11 GMASETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASD 51


>pdb|2CGF|A Chain A, A Radicicol Analogue Bound To The Atp Binding Site Of
          The N- Terminal Domain Of The Yeast Hsp90 Chaperone
          Length = 225

 Score = 68.9 bits (167), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 34/41 (82%), Positives = 35/41 (85%)

Query: 33 GDGVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          G   ETF FQAEI QLMSLIINT YSNKEIFLRELISN+SD
Sbjct: 11 GMASETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASD 51


>pdb|1A4H|A Chain A, Structure Of The N-Terminal Domain Of The Yeast Hsp90
          Chaperone In Complex With Geldanamycin
          Length = 230

 Score = 68.6 bits (166), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 33/37 (89%), Positives = 34/37 (91%)

Query: 37 ETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          ETF FQAEI QLMSLIINT YSNKEIFLRELISN+SD
Sbjct: 14 ETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASD 50


>pdb|2YGA|A Chain A, E88g-n92l Mutant Of N-term Hsp90 Complexed With
          Geldanamycin
          Length = 220

 Score = 68.6 bits (166), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 33/37 (89%), Positives = 34/37 (91%)

Query: 37 ETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          ETF FQAEI QLMSLIINT YSNKEIFLRELISN+SD
Sbjct: 4  ETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASD 40


>pdb|2YGF|A Chain A, L89v, L93i And V136m Mutant Of N-term Hsp90 Complexed
          With Geldanamycin
          Length = 220

 Score = 68.6 bits (166), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 33/37 (89%), Positives = 34/37 (91%)

Query: 37 ETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          ETF FQAEI QLMSLIINT YSNKEIFLRELISN+SD
Sbjct: 4  ETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASD 40


>pdb|1AH8|A Chain A, Structure Of The Orthorhombic Form Of The N-Terminal
          Domain Of The Yeast Hsp90 Chaperone
 pdb|1AH8|B Chain B, Structure Of The Orthorhombic Form Of The N-Terminal
          Domain Of The Yeast Hsp90 Chaperone
 pdb|1AH6|A Chain A, Structure Of The Tetragonal Form Of The N-Terminal
          Domain Of The Yeast Hsp90 Chaperone
          Length = 220

 Score = 68.6 bits (166), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 33/37 (89%), Positives = 34/37 (91%)

Query: 37 ETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          ETF FQAEI QLMSLIINT YSNKEIFLRELISN+SD
Sbjct: 4  ETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASD 40


>pdb|3K60|A Chain A, Crystal Structure Of N-Terminal Domain Of Plasmodium
          Falciparum Hsp90 (Pf07_0029) Bound To Adp
 pdb|3K60|B Chain B, Crystal Structure Of N-Terminal Domain Of Plasmodium
          Falciparum Hsp90 (Pf07_0029) Bound To Adp
          Length = 223

 Score = 68.6 bits (166), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 33/37 (89%), Positives = 35/37 (94%)

Query: 37 ETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          ETFAF A+I QLMSLIINTFYSNKEIFLRELISN+SD
Sbjct: 4  ETFAFNADIRQLMSLIINTFYSNKEIFLRELISNASD 40


>pdb|2BRE|A Chain A, Structure Of A Hsp90 Inhibitor Bound To The N-Terminus
          Of Yeast Hsp90.
 pdb|2BRE|B Chain B, Structure Of A Hsp90 Inhibitor Bound To The N-Terminus
          Of Yeast Hsp90.
 pdb|2VWC|A Chain A, Structure Of The Hsp90 Inhibitor Macbecin Bound To The
          N- Terminus Of Yeast Hsp90
          Length = 219

 Score = 68.6 bits (166), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 33/37 (89%), Positives = 34/37 (91%)

Query: 37 ETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          ETF FQAEI QLMSLIINT YSNKEIFLRELISN+SD
Sbjct: 4  ETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASD 40


>pdb|2YGE|A Chain A, E88g-n92l Mutant Of N-term Hsp90 Complexed With
          Geldanamycin
          Length = 220

 Score = 68.6 bits (166), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 33/37 (89%), Positives = 34/37 (91%)

Query: 37 ETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          ETF FQAEI QLMSLIINT YSNKEIFLRELISN+SD
Sbjct: 4  ETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASD 40


>pdb|2XX2|A Chain A, Macrolactone Inhibitor Bound To Hsp90 N-Term
 pdb|2XX2|B Chain B, Macrolactone Inhibitor Bound To Hsp90 N-Term
 pdb|2XX2|C Chain C, Macrolactone Inhibitor Bound To Hsp90 N-Term
 pdb|2XX2|D Chain D, Macrolactone Inhibitor Bound To Hsp90 N-Term
          Length = 214

 Score = 68.6 bits (166), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 33/37 (89%), Positives = 34/37 (91%)

Query: 37 ETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          ETF FQAEI QLMSLIINT YSNKEIFLRELISN+SD
Sbjct: 4  ETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASD 40


>pdb|1AM1|A Chain A, Atp Binding Site In The Hsp90 Molecular Chaperone
          Length = 213

 Score = 68.6 bits (166), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 33/37 (89%), Positives = 34/37 (91%)

Query: 37 ETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          ETF FQAEI QLMSLIINT YSNKEIFLRELISN+SD
Sbjct: 3  ETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASD 39


>pdb|1US7|A Chain A, Complex Of Hsp90 And P50
 pdb|2BRC|A Chain A, Structure Of A Hsp90 Inhibitor Bound To The N-Terminus
          Of Yeast Hsp90.
 pdb|2IWS|A Chain A, Radicicol Analogues Bound To The Atp Site Of Hsp90
 pdb|2IWU|A Chain A, Analogues Of Radicicol Bound To The Atp-Binding Site Of
          Hsp90
 pdb|2IWX|A Chain A, Analogues Of Radicicol Bound To The Atp-Binding Site Of
          Hsp90.
 pdb|1AMW|A Chain A, Adp Binding Site In The Hsp90 Molecular Chaperone
 pdb|2VW5|A Chain A, Structure Of The Hsp90 Inhibitor
          7-O-Carbamoylpremacbecin Bound To The N- Terminus Of
          Yeast Hsp90
 pdb|2VW5|B Chain B, Structure Of The Hsp90 Inhibitor
          7-O-Carbamoylpremacbecin Bound To The N- Terminus Of
          Yeast Hsp90
 pdb|2VW5|C Chain C, Structure Of The Hsp90 Inhibitor
          7-O-Carbamoylpremacbecin Bound To The N- Terminus Of
          Yeast Hsp90
 pdb|2VW5|D Chain D, Structure Of The Hsp90 Inhibitor
          7-O-Carbamoylpremacbecin Bound To The N- Terminus Of
          Yeast Hsp90
 pdb|2XD6|A Chain A, Hsp90 Complexed With A Resorcylic Acid Macrolactone.
 pdb|2XX4|A Chain A, Macrolactone Inhibitor Bound To Hsp90 N-Term
 pdb|2XX5|A Chain A, Macrolactone Inhibitor Bound To Hsp90 N-Term
          Length = 214

 Score = 68.6 bits (166), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 33/37 (89%), Positives = 34/37 (91%)

Query: 37 ETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          ETF FQAEI QLMSLIINT YSNKEIFLRELISN+SD
Sbjct: 4  ETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASD 40


>pdb|2WEP|A Chain A, Yeast Hsp90 N-Terminal Domain Li-Iv Mutant With Adp
 pdb|2WEQ|A Chain A, Yeast Hsp90 N-Terminal Domain Li-Iv Mutant With
          Geldanamycin
 pdb|2WER|A Chain A, Yeast Hsp90 N-Terminal Domain Li-Iv Mutant With
          Radicicol
 pdb|2WER|B Chain B, Yeast Hsp90 N-Terminal Domain Li-Iv Mutant With
          Radicicol
          Length = 220

 Score = 67.0 bits (162), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 31/37 (83%), Positives = 34/37 (91%)

Query: 37 ETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          ETF FQAEI QLMSLIINT YSNKEIFLRE++SN+SD
Sbjct: 4  ETFEFQAEITQLMSLIINTVYSNKEIFLREIVSNASD 40


>pdb|2CG9|A Chain A, Crystal Structure Of An Hsp90-Sba1 Closed Chaperone
          Complex
 pdb|2CG9|B Chain B, Crystal Structure Of An Hsp90-Sba1 Closed Chaperone
          Complex
          Length = 677

 Score = 66.6 bits (161), Expect = 3e-12,   Method: Composition-based stats.
 Identities = 33/37 (89%), Positives = 34/37 (91%)

Query: 37 ETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          ETF FQAEI QLMSLIINT YSNKEIFLRELISN+SD
Sbjct: 4  ETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASD 40


>pdb|2ESA|A Chain A, Grp94 N-Terminal Domain Bound To Geldanamycin: Effects
          Of Mutants 168- 169 Ks-Aa
          Length = 236

 Score = 61.2 bits (147), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 27/37 (72%), Positives = 32/37 (86%)

Query: 37 ETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          E FAFQAE+ ++M LIIN+ Y NKEIFLRELISN+SD
Sbjct: 10 EKFAFQAEVNRMMKLIINSLYKNKEIFLRELISNASD 46


>pdb|1U2O|A Chain A, Crystal Structure Of The N-Domain Of Grp94 Lacking The
          Charged Domain In Complex With Neca
 pdb|1U2O|B Chain B, Crystal Structure Of The N-Domain Of Grp94 Lacking The
          Charged Domain In Complex With Neca
 pdb|1TBW|A Chain A, Ligand Induced Conformational Shift In The N-Terminal
          Domain Of Grp94, Open Conformation
 pdb|1TBW|B Chain B, Ligand Induced Conformational Shift In The N-Terminal
          Domain Of Grp94, Open Conformation
 pdb|1TC0|A Chain A, Ligand Induced Conformational Shifts In The N-Terminal
          Domain Of Grp94, Open Conformation Complexed With The
          Physiological Partner Atp
 pdb|1TC0|B Chain B, Ligand Induced Conformational Shifts In The N-Terminal
          Domain Of Grp94, Open Conformation Complexed With The
          Physiological Partner Atp
 pdb|1TC6|A Chain A, Ligand Induced Conformational Shift In The N-Terminal
          Domain Of Grp94, Open Conformation Adp-Complex
 pdb|1TC6|B Chain B, Ligand Induced Conformational Shift In The N-Terminal
          Domain Of Grp94, Open Conformation Adp-Complex
 pdb|1U0Z|A Chain A, N-Domain Of Grp94 Lacking The Charged Domain In Complex
          With Radicicol
 pdb|1U0Z|B Chain B, N-Domain Of Grp94 Lacking The Charged Domain In Complex
          With Radicicol
 pdb|1YSZ|A Chain A, Crystal Structure Of The Unliganded Form Of Grp94, The
          Er Hsp90: Basis For Nucleotide-Induced Conformational
          Change, Grp94n(Delta)41 Apo Crystal Soaked With Neca
 pdb|1YT0|A Chain A, Crystal Structure Of The Unliganded Form Of Grp94, The
          Er Hsp90: Basis For Nucleotide-Induced Conformational
          Change, Grp94n(Delta)41 Apo Crystal Soaked With Adp
 pdb|1YT1|A Chain A, Crystal Structure Of The Unliganded Form Of Grp94, The
          Er Hsp90: Basis For Nucleotide-Induced Conformational
          Change, Grp94n(Delta)41 Apo Crystal
 pdb|1YT1|B Chain B, Crystal Structure Of The Unliganded Form Of Grp94, The
          Er Hsp90: Basis For Nucleotide-Induced Conformational
          Change, Grp94n(Delta)41 Apo Crystal
 pdb|2EXL|A Chain A, Grp94 N-Terminal Domain Bound To Geldanamycin
 pdb|2EXL|B Chain B, Grp94 N-Terminal Domain Bound To Geldanamycin
 pdb|2FYP|A Chain A, Grp94 In Complex With The Novel Hsp90 Inhibitor Radester
          Amine
 pdb|2FYP|B Chain B, Grp94 In Complex With The Novel Hsp90 Inhibitor Radester
          Amine
 pdb|2GFD|A Chain A, Grp94 In Complex With The Novel Hsp90 Inhibitor Radamide
 pdb|2GFD|B Chain B, Grp94 In Complex With The Novel Hsp90 Inhibitor Radamide
 pdb|2GQP|A Chain A, N-Domain Of Grp94 In Complex With The Novel Ligand
          N-Propyl Carboxyamido Adenosine
 pdb|2GQP|B Chain B, N-Domain Of Grp94 In Complex With The Novel Ligand
          N-Propyl Carboxyamido Adenosine
 pdb|2HCH|A Chain A, N-Domain Of Grp94 In Complex With The Novel Ligand N-(2-
          Amino)ethyl Carboxyamido Adenosine
 pdb|2HCH|B Chain B, N-Domain Of Grp94 In Complex With The Novel Ligand N-(2-
          Amino)ethyl Carboxyamido Adenosine
 pdb|2H8M|A Chain A, N-Domain Of Grp94 In Complex With The 2-Iodo-Neca
 pdb|2H8M|B Chain B, N-Domain Of Grp94 In Complex With The 2-Iodo-Neca
 pdb|2HG1|A Chain A, N-Domain Of Grp94 In Complex With The Novel Ligand N-(2-
          Hydroxyl)ethyl Carboxyamido Adenosine
 pdb|2HG1|B Chain B, N-Domain Of Grp94 In Complex With The Novel Ligand N-(2-
          Hydroxyl)ethyl Carboxyamido Adenosine
 pdb|3O2F|A Chain A, Structure Of The N-Domain Of Grp94 Bound To The Hsp90
          Inhibitor Pu-H54
 pdb|3O2F|B Chain B, Structure Of The N-Domain Of Grp94 Bound To The Hsp90
          Inhibitor Pu-H54
          Length = 236

 Score = 61.2 bits (147), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 27/37 (72%), Positives = 32/37 (86%)

Query: 37 ETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          E FAFQAE+ ++M LIIN+ Y NKEIFLRELISN+SD
Sbjct: 10 EKFAFQAEVNRMMKLIINSLYKNKEIFLRELISNASD 46


>pdb|1QY5|A Chain A, Crystal Structure Of The N-Domain Of The Er Hsp90
          Chaperone Grp94 In Complex With The Specific Ligand
          Neca
 pdb|1QY8|A Chain A, Crystal Structure Of The N-domain Of The Er Hsp90
          Chaperone Grp94 In Complex With Radicicol
 pdb|1QYE|A Chain A, Crystal Structure Of The N-domain Of The Er Hsp90
          Chaperone Grp94 In Complex With
          2-chlorodideoxyadenosine
          Length = 269

 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 27/37 (72%), Positives = 32/37 (86%)

Query: 37 ETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          E FAFQAE+ ++M LIIN+ Y NKEIFLRELISN+SD
Sbjct: 6  EKFAFQAEVNRMMKLIINSLYKNKEIFLRELISNASD 42


>pdb|1U0Y|A Chain A, N-Domain Of Grp94, With The Charged Domain, In Complex
          With The Novel Ligand N-Propyl Carboxyamido Adenosine
 pdb|1YT2|A Chain A, Crystal Structure Of The Unliganded Form Of Grp94, The
          Er Hsp90: Basis For Nucleotide-Induced Conformational
          Change, Grp94n Apo Crystal
          Length = 273

 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 27/37 (72%), Positives = 32/37 (86%)

Query: 37 ETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          E FAFQAE+ ++M LIIN+ Y NKEIFLRELISN+SD
Sbjct: 10 EKFAFQAEVNRMMKLIINSLYKNKEIFLRELISNASD 46


>pdb|2IOR|A Chain A, Crystal Structure Of The N-Terminal Domain Of Htpg, The
          Escherichia Coli Hsp90, Bound To Adp
          Length = 235

 Score = 59.7 bits (143), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 29/55 (52%), Positives = 39/55 (70%), Gaps = 1/55 (1%)

Query: 35 GVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDVQN-IDFTGNQTQDLW 88
          G ET  FQ+E+ QL+ L+I++ YSNKEIFLRELISN+SD  + + F      DL+
Sbjct: 23 GQETRGFQSEVKQLLHLMIHSLYSNKEIFLRELISNASDAADKLRFRALSNPDLY 77


>pdb|2O1U|A Chain A, Structure Of Full Length Grp94 With Amp-Pnp Bound
 pdb|2O1U|B Chain B, Structure Of Full Length Grp94 With Amp-Pnp Bound
 pdb|2O1V|A Chain A, Structure Of Full Length Grp94 With Adp Bound
 pdb|2O1V|B Chain B, Structure Of Full Length Grp94 With Adp Bound
          Length = 666

 Score = 59.7 bits (143), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 27/37 (72%), Positives = 32/37 (86%)

Query: 37 ETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          E FAFQAE+ ++M LIIN+ Y NKEIFLRELISN+SD
Sbjct: 23 EKFAFQAEVNRMMKLIINSLYKNKEIFLRELISNASD 59


>pdb|2O1W|A Chain A, Structure Of N-Terminal Plus Middle Domains (N+m) Of
          Grp94
 pdb|2O1W|B Chain B, Structure Of N-Terminal Plus Middle Domains (N+m) Of
          Grp94
 pdb|2O1W|C Chain C, Structure Of N-Terminal Plus Middle Domains (N+m) Of
          Grp94
 pdb|2O1W|D Chain D, Structure Of N-Terminal Plus Middle Domains (N+m) Of
          Grp94
 pdb|2O1W|E Chain E, Structure Of N-Terminal Plus Middle Domains (N+m) Of
          Grp94
          Length = 506

 Score = 59.3 bits (142), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 27/37 (72%), Positives = 32/37 (86%)

Query: 37 ETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          E FAFQAE+ ++M LIIN+ Y NKEIFLRELISN+SD
Sbjct: 23 EKFAFQAEVNRMMKLIINSLYKNKEIFLRELISNASD 59


>pdb|2IOP|A Chain A, Crystal Structure Of Full-Length Htpg, The Escherichia
          Coli Hsp90, Bound To Adp
 pdb|2IOP|B Chain B, Crystal Structure Of Full-Length Htpg, The Escherichia
          Coli Hsp90, Bound To Adp
 pdb|2IOP|C Chain C, Crystal Structure Of Full-Length Htpg, The Escherichia
          Coli Hsp90, Bound To Adp
 pdb|2IOP|D Chain D, Crystal Structure Of Full-Length Htpg, The Escherichia
          Coli Hsp90, Bound To Adp
 pdb|2IOQ|A Chain A, Crystal Structure Of Full-Length Htpg, The Escherichia
          Coli Hsp90
 pdb|2IOQ|B Chain B, Crystal Structure Of Full-Length Htpg, The Escherichia
          Coli Hsp90
          Length = 624

 Score = 56.2 bits (134), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 29/55 (52%), Positives = 39/55 (70%), Gaps = 1/55 (1%)

Query: 35 GVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDVQN-IDFTGNQTQDLW 88
          G ET  FQ+E+ QL+ L+I++ YSNKEIFLRELISN+SD  + + F      DL+
Sbjct: 3  GQETRGFQSEVKQLLHLMIHSLYSNKEIFLRELISNASDAADKLRFRALSNPDLY 57


>pdb|1Y4S|A Chain A, Conformation Rearrangement Of Heat Shock Protein 90 Upon
          Adp Binding
 pdb|1Y4S|B Chain B, Conformation Rearrangement Of Heat Shock Protein 90 Upon
          Adp Binding
 pdb|1Y4U|A Chain A, Conformation Rearrangement Of Heat Shock Protein 90 Upon
          Adp Binding
 pdb|1Y4U|B Chain B, Conformation Rearrangement Of Heat Shock Protein 90 Upon
          Adp Binding
          Length = 559

 Score = 55.8 bits (133), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 29/55 (52%), Positives = 39/55 (70%), Gaps = 1/55 (1%)

Query: 35 GVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDVQN-IDFTGNQTQDLW 88
          G ET  FQ+E+ QL+ L+I++ YSNKEIFLRELISN+SD  + + F      DL+
Sbjct: 3  GQETRGFQSEVKQLLHLMIHSLYSNKEIFLRELISNASDAADKLRFRALSNPDLY 57


>pdb|3IED|A Chain A, Crystal Structure Of N-Terminal Domain Of Plasmodium
          Falciparum Hsp90 (Pf14_0417) In Complex With Amppn
          Length = 272

 Score = 53.9 bits (128), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 21/41 (51%), Positives = 34/41 (82%)

Query: 33 GDGVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD 73
          G  VE + F+AE+ ++M +I+N+ Y++K++FLRELISN+SD
Sbjct: 21 GSPVEKYNFKAEVNKVMDIIVNSLYTDKDVFLRELISNASD 61


>pdb|3PEH|A Chain A, Crystal Structure Of The N-Terminal Domain Of An Hsp90
          From Plasmodium Falciparum, Pfl1070c In The Presence Of
          A Thienopyrimidine Derivative
 pdb|3PEH|B Chain B, Crystal Structure Of The N-Terminal Domain Of An Hsp90
          From Plasmodium Falciparum, Pfl1070c In The Presence Of
          A Thienopyrimidine Derivative
 pdb|3PEJ|A Chain A, Crystal Structure Of The N-Terminal Domain Of An Hsp90
          From Plasmodium Falciparum, Pfl1070c In The Presence Of
          Macbecin
 pdb|3PEJ|B Chain B, Crystal Structure Of The N-Terminal Domain Of An Hsp90
          From Plasmodium Falciparum, Pfl1070c In The Presence Of
          Macbecin
          Length = 281

 Score = 52.4 bits (124), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 37/51 (72%), Gaps = 1/51 (1%)

Query: 30 QSSGDGVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSD-VQNIDF 79
          Q   + +E+  +Q E+ +LM +I+N+ Y+ KE+FLRELISN++D ++ I F
Sbjct: 17 QGPTESMESHQYQTEVTRLMDIIVNSLYTQKEVFLRELISNAADALEKIRF 67


>pdb|2AKP|A Chain A, Hsp90 Delta24-n210 Mutant
 pdb|2AKP|B Chain B, Hsp90 Delta24-n210 Mutant
          Length = 186

 Score = 33.5 bits (75), Expect = 0.030,   Method: Compositional matrix adjust.
 Identities = 15/16 (93%), Positives = 16/16 (100%)

Query: 58 SNKEIFLRELISNSSD 73
          SNKEIFLRELISN+SD
Sbjct: 1  SNKEIFLRELISNASD 16


>pdb|1QAS|A Chain A, 1-Phosphatidylinositol-4,5-Bisphosphate Phosphodiesterase
           Delta 1
 pdb|1QAS|B Chain B, 1-Phosphatidylinositol-4,5-Bisphosphate Phosphodiesterase
           Delta 1
 pdb|1QAT|A Chain A, 1-Phosphatidylinositol-4,5-Bisphosphate Phosphodiesterase
           Delta Complex With Samarium (Iii) Chloride
 pdb|1QAT|B Chain B, 1-Phosphatidylinositol-4,5-Bisphosphate Phosphodiesterase
           Delta Complex With Samarium (Iii) Chloride
          Length = 622

 Score = 28.1 bits (61), Expect = 1.3,   Method: Composition-based stats.
 Identities = 24/91 (26%), Positives = 42/91 (46%), Gaps = 4/91 (4%)

Query: 5   QSSGDAITLGLIERVTKNTTLMADNQSSGDGVETFAFQAEIAQLMSLIINTFYSNKEIFL 64
           + +G A+ L LIER   + T  A  Q + DG   +   A+     SL     Y + +  L
Sbjct: 110 EEAGPALALSLIERYEPSETAKAQRQMTKDGFLMYLLSAD-GNAFSLAHRRVYQDMDQPL 168

Query: 65  RE-LISNSSDVQNID--FTGNQTQDLWCRSL 92
              L+S+S +   ++   TG  + + + R+L
Sbjct: 169 SHYLVSSSHNTYLLEDQLTGPSSTEAYIRAL 199


>pdb|1DJG|A Chain A, Phosphoinositide-Specific Phospholipase C-Delta1 From Rat
           Complexed With Lanthanum
 pdb|1DJG|B Chain B, Phosphoinositide-Specific Phospholipase C-Delta1 From Rat
           Complexed With Lanthanum
 pdb|1DJH|A Chain A, Phosphoinositide-Specific Phospholipase C-Delta1 From Rat
           Complexed With Barium
 pdb|1DJH|B Chain B, Phosphoinositide-Specific Phospholipase C-Delta1 From Rat
           Complexed With Barium
 pdb|1DJI|A Chain A, Phosphoinositide-Specific Phospholipase C-Delta1 From Rat
           Complexed With Calcium
 pdb|1DJI|B Chain B, Phosphoinositide-Specific Phospholipase C-Delta1 From Rat
           Complexed With Calcium
 pdb|1DJW|A Chain A, Phosphoinositide-Specific Phospholipase C-Delta1 From Rat
           Complexed With Inositol-2-Methylene-1,2-Cyclic-
           Monophosphonate
 pdb|1DJW|B Chain B, Phosphoinositide-Specific Phospholipase C-Delta1 From Rat
           Complexed With Inositol-2-Methylene-1,2-Cyclic-
           Monophosphonate
 pdb|1DJX|A Chain A, Phosphoinositide-Specific Phospholipase C-Delta1 From Rat
           Complexed With Inositol-1,4,5-Trisphosphate
 pdb|1DJX|B Chain B, Phosphoinositide-Specific Phospholipase C-Delta1 From Rat
           Complexed With Inositol-1,4,5-Trisphosphate
 pdb|1DJY|A Chain A, Phosphoinositide-Specific Phospholipase C-Delta1 From Rat
           Complexed With Inositol-2,4,5-Trisphosphate
 pdb|1DJY|B Chain B, Phosphoinositide-Specific Phospholipase C-Delta1 From Rat
           Complexed With Inositol-2,4,5-Trisphosphate
 pdb|1DJZ|A Chain A, Phosphoinositide-Specific Phospholipase C-Delta1 From Rat
           Complexed With Inositol-4,5-Bisphosphate
 pdb|1DJZ|B Chain B, Phosphoinositide-Specific Phospholipase C-Delta1 From Rat
           Complexed With Inositol-4,5-Bisphosphate
 pdb|2ISD|A Chain A, Phosphoinositide-Specific Phospholipase C-Delta1 From Rat
 pdb|2ISD|B Chain B, Phosphoinositide-Specific Phospholipase C-Delta1 From Rat
          Length = 624

 Score = 28.1 bits (61), Expect = 1.4,   Method: Composition-based stats.
 Identities = 24/91 (26%), Positives = 42/91 (46%), Gaps = 4/91 (4%)

Query: 5   QSSGDAITLGLIERVTKNTTLMADNQSSGDGVETFAFQAEIAQLMSLIINTFYSNKEIFL 64
           + +G A+ L LIER   + T  A  Q + DG   +   A+     SL     Y + +  L
Sbjct: 112 EEAGPALALSLIERYEPSETAKAQRQMTKDGFLMYLLSAD-GNAFSLAHRRVYQDMDQPL 170

Query: 65  RE-LISNSSDVQNID--FTGNQTQDLWCRSL 92
              L+S+S +   ++   TG  + + + R+L
Sbjct: 171 SHYLVSSSHNTYLLEDQLTGPSSTEAYIRAL 201


>pdb|1ZYN|A Chain A, Oxidized Structure Of The N-Terminal Domain Of
          Salmonella Typhimurium Ahpf
 pdb|1ZYN|B Chain B, Oxidized Structure Of The N-Terminal Domain Of
          Salmonella Typhimurium Ahpf
 pdb|1ZYP|A Chain A, Synchrotron Reduced Form Of The N-Terminal Domain Of
          Salmonella Typhimurium Ahpf
 pdb|1ZYP|B Chain B, Synchrotron Reduced Form Of The N-Terminal Domain Of
          Salmonella Typhimurium Ahpf
          Length = 202

 Score = 27.7 bits (60), Expect = 1.7,   Method: Compositional matrix adjust.
 Identities = 21/71 (29%), Positives = 33/71 (46%), Gaps = 5/71 (7%)

Query: 16 IERVTKNTTLMADNQSSGDGVETFAFQAEIAQLMSLIINTFYSNKEIFLRE---LISNSS 72
          +E++TK   L+A    S    E     AEIA+L   +  TF  +  + +R+   LI+N  
Sbjct: 14 LEKLTKPVELIATLDDSAKSAEIKELLAEIAELSDKV--TFKEDNTLPVRKPSFLITNPG 71

Query: 73 DVQNIDFTGNQ 83
            Q   F G+ 
Sbjct: 72 SQQGPRFAGSP 82


>pdb|1HYU|A Chain A, Crystal Structure Of Intact Ahpf
          Length = 521

 Score = 26.9 bits (58), Expect = 3.2,   Method: Composition-based stats.
 Identities = 21/70 (30%), Positives = 33/70 (47%), Gaps = 5/70 (7%)

Query: 16 IERVTKNTTLMADNQSSGDGVETFAFQAEIAQLMSLIINTFYSNKEIFLRE---LISNSS 72
          +E++TK   L+A    S    E     AEIA+L   +  TF  +  + +R+   LI+N  
Sbjct: 14 LEKLTKPVELIATLDDSAKSAEIKELLAEIAELSDKV--TFKEDNTLPVRKPSFLITNPG 71

Query: 73 DVQNIDFTGN 82
            Q   F G+
Sbjct: 72 SQQGPRFAGS 81


  Database: pdbaa
    Posted date:  Mar 3, 2013 10:34 PM
  Number of letters in database: 14,973,337
  Number of sequences in database:  62,578
  
Lambda     K      H
   0.316    0.129    0.352 

Lambda     K      H
   0.267   0.0410    0.140 


Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 2,403,191
Number of Sequences: 62578
Number of extensions: 74090
Number of successful extensions: 211
Number of sequences better than 100.0: 75
Number of HSP's better than 100.0 without gapping: 73
Number of HSP's successfully gapped in prelim test: 2
Number of HSP's that attempted gapping in prelim test: 138
Number of HSP's gapped (non-prelim): 75
length of query: 93
length of database: 14,973,337
effective HSP length: 60
effective length of query: 33
effective length of database: 11,218,657
effective search space: 370215681
effective search space used: 370215681
T: 11
A: 40
X1: 16 ( 7.3 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.6 bits)
S2: 45 (21.9 bits)